Literature DB >> 825677

Postoperative long term chemotherapy for advanced gastric cancer.

N Kaibara, K Soejima, T Nakamura, K Inokuchi.   

Abstract

A postoperative long term chemotherapy was carried out against stage IV gastric cancer with Mitomycin-C, Futraful and a plant polysaccharide, PS-K. The 2-year survival rate was 15 per cent in patients who received an intraoperative Mitomycin-C alone, while it increased to 34 per cent in those receiving the anticancer agents for a prolonged period. The postoperative long term chemotherapy is assumed to be an effective means of improving the therapeutical results of gastric cancer.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 825677     DOI： 10.1007/BF02468887

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN： 0047-1909


  10 in total

1.  Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.

Authors:  K Nomoto; C Yoshikumi; K Matsunaga; T Fujii; K Takeya
Journal:  Gan       Date:  1975-08

2.  "SUPPRESSIVE" CHEMOTHERAPY IN BRONCHOGENIC CARCINOMA: A RANDOMIZED PROSPECTIVE CLINICAL TRIAL.

Authors:  H HORWITZ; T L WRIGHT; H PERRY; C M BARRETT
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1965-03

3.  Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and-or allogeneic bone marrow transplantation.

Authors:  T Hattori; A Mori; K Hirata; I Ito
Journal:  Gan       Date:  1972-10

4.  Protein-bound polysaccharide preparation, PS-K, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use.

Authors:  S Tsukagoshi; F Ophashi
Journal:  Gan       Date:  1974-12

5.  The general rules for The gastric cancer study in surgery.

Authors: 
Journal:  Jpn J Surg       Date:  1973-03

6.  Importance of dose schedules in adjuvant chemotherapy.

Authors:  K Karrar
Journal:  Cancer Chemother Rep       Date:  1972-02

7.  Extended surgical adjuvant chemotherapy for breast carcinoma.

Authors:  R T Long; W L Donegan; A M Evans
Journal:  Am J Surg       Date:  1969-05       Impact factor: 2.565

8.  Adjuvant long-term chemotherapy in complex treatment of operable breast cancer.

Authors:  S A Kholdin; L Y Deemarsky; J L Bavly
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

9.  Spleen and bone marrow shielding technique in intraoperative adjuvant chemotherapy for gastric cancer.

Authors:  K Inokuchi; T Nakamura; S Ienaga; T Akiyoshi; T Ikeda
Journal:  J Antibiot (Tokyo)       Date:  1966-03       Impact factor: 2.649

10.  Prophylactic treatment of cancer; the use of chemotherapeutic agents to prevent tumor metastasis.

Authors:  E P CRUZ; G O MCDONALD; W H COLE
Journal:  Surgery       Date:  1956-08       Impact factor: 3.982
  10 in total
  10 in total

1.  Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.

Authors:  Toshiro Okuyama; Daisuke Korenaga; Ai Edagawa; Shinji Itoh; Eiji Oki; Hirofumi Kawanaka; Yasuharu Ikeda; Yoshihiro Kakeji; Masahiro Tateishi; Shunichi Tsujitani; Kenji Takenaka; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-27       Impact factor: 2.549

2.  Possible role of lymph node dissection in the surgical treatment of gastric cancer with disseminating peritoneal metastasis.

Authors:  N Kaibara; T Okamoto; O Kimura; Y Iitsuka; M Takebayashi; E Yurugi; H Nishidoi; H Tamura; S Koga
Journal:  Jpn J Surg       Date:  1983-09

3.  Intensified cancer themotherapy by induction of hepatic drug-metabolizing enzymes as a trial for the treatment for stomach cancer.

Authors:  S Fujimoto; K Itoh; T Tazawa; T Hosaka; S Karaki; S Kawanomoto; T Hikosaka; K Gambe
Journal:  Jpn J Surg       Date:  1980-03

4.  Clinical evaluation of prolonged chemotherapy combined with induction of hepatic drug-metabolizing enzymes as an adjuvant for treating patients with gastric cancer.

Authors:  S Fujimoto; M Miyazaki; Y Kitsukawa; K Okui; T Hosaka; S Karaki; S Kawanomoto
Journal:  Jpn J Surg       Date:  1983-11

5.  Combination chemoimmunotherapy for advanced gastric carcinoma.

Authors:  T Akiyoshi; M Kawaguchi; S Arinaga; S Miyazaki; F Koba; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1984-05

6.  Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients.

Authors:  T Hattori; M Niimoto; T Koh; A Nakano; M Oride; W Takiyama; K Nishimawari
Journal:  Jpn J Surg       Date:  1979-06

7.  Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection.

Authors:  T Kano; R Kumashiro; H Masuda; R Tamada; K Inokuchi
Journal:  Jpn J Surg       Date:  1983-03

8.  Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.

Authors:  T Kano; R Kumashiro; R Tamada; Y Kodama; K Inokuchi
Journal:  Jpn J Surg       Date:  1981

9.  Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach.

Authors:  Y Kodama; T Kano; R Tamada; R Kumashiro; T Okamura; K Inokuchi
Journal:  Jpn J Surg       Date:  1982

Review 10.  Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review.

Authors:  Chun Sing Lam; Lok Pui Cheng; Li Min Zhou; Yin Ting Cheung; Zhong Zuo
Journal:  Chin Med       Date:  2020-07-25       Impact factor: 5.455
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.